Risankizumab (Skyrizi®) Demonstrates Significant Improvements in Clinical Remission and Endoscopic Response in Two Phase 3 Induction Studies in Patients with Crohn’s Disease

Managing Postoperative Crohn’s Disease Made Easy

Dispatches from the GUILD Conference 2021

Teduglutide and Short Bowel Syndrome in Children

How Common are Pediatric Feeding Disorders?

Bezoars: Recognizing and Managing These Stubborn, Sometimes Hairy, Roadblocks of the Gastrointestinal Tract

Endoscopic Treatment of Symptomatic Zenker’s Diverticula